Skip to main content
. 2020 Aug 5;21(9):e50912. doi: 10.15252/embr.202050912

Figure 7. Model of CSAG2 regulation of SIRT1 and tumorigenesis.

Figure 7

A schematic model for how aberrant transcriptional activation of CSAG2 in cancer leads to enhanced SIRT1 activity and regulation of key tumor regulatory pathways. Note that the oncogenic potential of CSAG2 is likely attribute to multiple SIRT1 targets and pathways.